BACKGROUND: Multiple randomized controlled trials have demonstrated that mailed fecal testing programs are effective in increasing colorectal cancer screening participation. However, few healthcare organization in the US have Implemented such programs. METHODS: Stakeholders from one clinic in an integrated healthcare system in Washington State initiated collaboration with researchers with expertise in CRC screening, aiming to increase screening rates at their clinic. Age-eligible individuals who were overdue for CRC screening and had previously completed a fecal test were randomized to receive mailed fecal immunochemical test kits (FIT) at the start of the project (Early) or 6 months later (Late). Outcomes included comparing FIT completion at 6 months by randomization group, and overall CRC screening rates at 12 months. We also assessed implementation facilitators and challenges. RESULTS: Overall 2,421 FIT tests were mailed at a cost of $10,739. At 6 months, FIT completion was significantly higher among the Early compared to the Late group (62% vs.47%, p <0.001). By 12 months, after both groups had received mailings, 71% in each group had completed a FIT. The clinic's overall CRC screening rate was 75.1% at baseline and 78.0% 12 months later. Key constructs associated with successful program implementation included strong stakeholder involvement, use of evidence-based strategies, simplicity, and low cost. Challenges included lack of a plan for maintaining the program. DISCUSSION: Collaboration between clinic stakeholders and researchers led to a successful project that rapidly increased CRC screening rates. However, institutional normalization of the program would be required to maintain it.
BACKGROUND: Multiple randomized controlled trials have demonstrated that mailed fecal testing programs are effective in increasing colorectal cancer screening participation. However, few healthcare organization in the US have Implemented such programs. METHODS: Stakeholders from one clinic in an integrated healthcare system in Washington State initiated collaboration with researchers with expertise in CRC screening, aiming to increase screening rates at their clinic. Age-eligible individuals who were overdue for CRC screening and had previously completed a fecal test were randomized to receive mailed fecal immunochemical test kits (FIT) at the start of the project (Early) or 6 months later (Late). Outcomes included comparing FIT completion at 6 months by randomization group, and overall CRC screening rates at 12 months. We also assessed implementation facilitators and challenges. RESULTS: Overall 2,421 FIT tests were mailed at a cost of $10,739. At 6 months, FIT completion was significantly higher among the Early compared to the Late group (62% vs.47%, p <0.001). By 12 months, after both groups had received mailings, 71% in each group had completed a FIT. The clinic's overall CRC screening rate was 75.1% at baseline and 78.0% 12 months later. Key constructs associated with successful program implementation included strong stakeholder involvement, use of evidence-based strategies, simplicity, and low cost. Challenges included lack of a plan for maintaining the program. DISCUSSION: Collaboration between clinic stakeholders and researchers led to a successful project that rapidly increased CRC screening rates. However, institutional normalization of the program would be required to maintain it.
Authors: Timothy R Church; Mark W Yeazel; Resa M Jones; Laura K Kochevar; Gavin D Watt; Steven J Mongin; Jill E Cordes; Deborah Engelhard Journal: J Natl Cancer Inst Date: 2004-05-19 Impact factor: 13.506
Authors: Iris Vogelaar; Marjolein van Ballegooijen; Deborah Schrag; Rob Boer; Sidney J Winawer; J Dik F Habbema; Ann G Zauber Journal: Cancer Date: 2006-10-01 Impact factor: 6.860
Authors: David W Baker; Tiffany Brown; David R Buchanan; Jordan Weil; Kate Balsley; Lauren Ranalli; Ji Young Lee; Kenzie A Cameron; M Rosario Ferreira; Quinn Stephens; Shira N Goldman; Alred Rademaker; Michael S Wolf Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Laura Mae Baldwin; Leah Tuzzio; Sheryl Catz; Alison Cole; Sally W Vernon Journal: J Am Board Fam Med Date: 2016 Mar-Apr Impact factor: 2.657
Authors: Beverly B Green; Ching-Yun Wang; Melissa L Anderson; Jessica Chubak; Richard T Meenan; Sally W Vernon; Sharon Fuller Journal: Ann Intern Med Date: 2013-03-05 Impact factor: 25.391
Authors: Christopher D Jensen; Douglas A Corley; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Amy R Marks; Joanne E Schottinger; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Carrie N Klabunde; Charles P Quesenberry; Theodore R Levin; Pauline A Mysliwiec Journal: Ann Intern Med Date: 2016-01-26 Impact factor: 25.391
Authors: Siu Hing Lo; Stephen Halloran; Julia Snowball; Helen Seaman; Jane Wardle; Christian von Wagner Journal: Gut Date: 2014-05-07 Impact factor: 23.059
Authors: Gloria D Coronado; Jamie H Thompson; Amanda F Petrik; Denis B Nyongesa; Michael C Leo; Melissa Castillo; Brittany Younger; Anne Escaron; Alex Chen Journal: J Am Board Fam Med Date: 2019 May-Jun Impact factor: 2.657
Authors: Jamie H Thompson; Melinda M Davis; LeAnn Michaels; Jennifer S Rivelli; Melissa L Castillo; Brittany M Younger; Marta Castro; Sacha L Reich; Gloria D Coronado Journal: J Am Board Fam Med Date: 2019 May-Jun Impact factor: 2.657
Authors: Jennifer Coury; Edward J Miech; Patricia Styer; Amanda F Petrik; Kelly E Coates; Beverly B Green; Laura-Mae Baldwin; Jean A Shapiro; Gloria D Coronado Journal: Implement Sci Commun Date: 2021-01-11
Authors: Laura-Mae Baldwin; Jennifer L Schneider; Malaika Schwartz; Jennifer S Rivelli; Beverly B Green; Amanda F Petrik; Gloria D Coronado Journal: BMC Health Serv Res Date: 2020-02-21 Impact factor: 2.655